Biotech · Private company
Arbor Pharmaceuticals, Inc.
Track this companyFree. Adds Arbor Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials81 recruiting or active
Pipeline programs14From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline14
- Amphetamine SulfatePhase 3 · Attention Deficit Hyperactivity DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Azilsartan Medoxomil High-dose (40 mg)Phase 3 · HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Azilsartan Medoxomil Low-dosePhase 3 · HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Azilsartan Medoxomil Medium-dose (20 mg)Phase 3 · HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- LosartanPhase 3 · HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- AR09 solutionPhase 1 · AnesthesiaClinicalTrials.gov · fetched Nov 12, 2026
- Alprazolam 2 mgAbuse PotentialClinicalTrials.gov · fetched Nov 12, 2026
- AR11Attention Deficit Hyperactivity Disorder (ADHD)ClinicalTrials.gov · fetched Nov 12, 2026
- Gabapentin Enacarbil Immediate Release (GE-IR) 200 mgAbuse PotentialClinicalTrials.gov · fetched Nov 12, 2026
- Gabapentin Enacarbil Immediate Release (GE-IR) 450 mgAbuse PotentialClinicalTrials.gov · fetched Nov 12, 2026
- Gabapentin Enacarbil Immediate Release (GE-IR) 700 mgAbuse PotentialClinicalTrials.gov · fetched Nov 12, 2026
- GE-IR 200 mgAbuse PotentialClinicalTrials.gov · fetched Nov 12, 2026
- GE-IR 450 mgAbuse PotentialClinicalTrials.gov · fetched Nov 12, 2026
- Oxycodone 20 mgAbuse PotentialClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Abuse Potential of HORIZANT With and Without Oxycodone in Healthy, Nondependent Recreational Opioid UsersPHASE4 · COMPLETED · started Jan 31, 2022ClinicalTrials.gov NCT06247488 · fetched Nov 12, 2026
- An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug UsersPHASE4 · COMPLETED · started Sep 28, 2021ClinicalTrials.gov NCT06097676 · fetched Nov 12, 2026
- A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain DiseasePHASE2 · RECRUITING · started Nov 6, 2020ClinicalTrials.gov NCT04222062 · fetched Nov 12, 2026
- Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine SulfatePHASE3 · COMPLETED · started Sep 18, 2018ClinicalTrials.gov NCT03659929 · fetched Nov 12, 2026
- Vigilant ObservatIon of GlIadeL WAfer ImplaNT RegistryCOMPLETED · started Apr 26, 2016ClinicalTrials.gov NCT02684838 · fetched Nov 12, 2026
- An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With HypertensionPHASE3 · COMPLETED · started Mar 30, 2015ClinicalTrials.gov NCT02235909 · fetched Nov 12, 2026
- Phase I Rising-dose Study to Assess Tolerability, Safety, Pharmacokinetics, Pharmacodynamics of AR09PHASE1 · TERMINATED · started Dec 1, 2013ClinicalTrials.gov NCT02027155 · fetched Nov 12, 2026
- Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom SettingPHASE4 · COMPLETED · started Dec 1, 2013ClinicalTrials.gov NCT01986062 · fetched Nov 12, 2026